INDERO CRO
LIVE

Serial Number

79412141

Owner

Indero Inc.

Attorney

Charles G. Zug

Filing Date

Jun 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

INDERO CRO Trademark

Serial Number: 79412141 • Registration: 8258151

INDERO CRO is a trademark filed by Indero Inc. on June 27, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Indero Inc.

300-3530 Boul Saint-Laurent

Entity Type: 03

Trademark Details

Filing Date

June 27, 2024

Registration Date

May 19, 2026

Published for Opposition

March 31, 2026

Goods & Services

Medical testing services in relation to subjects in clinical trials of pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products

Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information on the design and management of clinical trials; Scientific research in relation to the design and management of clinical trials and development of clinical trials in the fields of pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Medical and scientific research, namely, designing, developing protocols for, organizing, conducting, monitoring, and managing clinical trials and preclinical and nonclinical research studies, research support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products for others; Consulting services for others in the field of medical and scientific research, namely, clinical trials and preclinical and nonclinical research studies, research support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Calibration services, namely, the calibration of electronic data for the purpose of conducting clinical trials and preclinical and nonclinical research studies related to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Electronic storage of data in the field of clinical trials and preclinical and nonclinical research studies related to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Medical research services, namely, research assistance services and research project management services for the purpose of designing and conducting clinical trials in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Scientific research in relation to the designing and conducting of clinical trials in the fields of data management and biostatistics; Providing scientific information on the design and management of clinical trials and preclinical and nonclinical research studies; Research assistance services and research project management services for the purpose of designing and conducting clinical trials in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, and medical devices

Distributorship services for others in the fields of cameras and imaging equipment for use in the field of dermatology and laboratory equipment for use in the field of clinical research; electronic data collection services for business purposes in the field of preclinical and nonclinical research, clinical trials and technical studies related to pharmaceutical and biological drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; collection and compilation of information into computer databases in the field of preclinical and nonclinical research, clinical trials and technical studies related to pharmaceutical and biological drugs for human and veterinary use

Regulatory compliance consulting and advisory services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 28, 2026 OPNX
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 19, 2026 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 11, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 11, 2026 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2026 CNSA
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Mar 5, 2026 UNTD
RESPONSE TO ITU OFFICE ACTION ENTERED
Feb 26, 2026 IROA
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 26, 2026 PARI
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 25, 2026 AITU
EXAMINER'S AMENDMENT ENTERED
Feb 20, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 20, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 20, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 20, 2026 CNEA
TEAS REQUEST TO DIVIDE RECEIVED
Feb 10, 2026 ERTD
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 9, 2025 GNFN
FINAL REFUSAL E-MAILED
Sep 9, 2025 GNFR
FINAL REFUSAL WRITTEN
Sep 9, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 8, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 18, 2025 RFCS
REFUSAL PROCESSED BY MPU
Feb 18, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 7, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 6, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 26, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 13, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2024 REPR